Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Progression-related outcomes of teriflunomide in multiple sclerosis clinical trials.
Journal: Frontiers in neurology
Published: May 15, 2026
The Impact of COVID-19 Infection and Vaccination on Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody Disease: A Narrative Review.
Journal: Journal of central nervous system disease
Published: January 29, 2026
The Impact of Multiple Sclerosis on Work Productivity: A Preliminary Look at the North American Registry for Care and Research in Multiple Sclerosis.
Journal: NeuroSci
Published: May 05, 2025
Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohort.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 18, 2024
Making an accurate diagnosis of anterior mediastinal lesions: a proposal for a new diagnostic algorithm from the BTOG Thymic Malignancies Special Interest Group.
Journal: Clinical radiology
Published: January 04, 2024
A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study.
Journal: Neurodegenerative disease management
Published: August 03, 2023
Identification and management of subclinical disease activity in early multiple sclerosis: a review.
Identification and management of subclinical disease activity in early multiple sclerosis: a review.
Journal: Journal of neurology
Published: June 30, 2023
Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: Pathogenesis, risk of infection, and disease management.
Journal: Multiple sclerosis and related disorders
Published: April 24, 2023
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 04, 2023
Bruton's Tyrosine Kinase Inhibitors: The Next Frontier of B-Cell-Targeted Therapies for Cancer, Autoimmune Disorders, and Multiple Sclerosis.
Journal: Journal of clinical medicine
Published: September 06, 2022
Disease stability over five years in people with multiple sclerosis treated with cladribine tablets: a plain language summary.
Journal: Neurodegenerative disease management
Published: August 26, 2022
Last Updated: 09/26/2026